|
|
News Breaks | | | | September 14, 2012 | | 06:26 EDT |  | EXAC | Exactech continues to be undervalued, says Benchmark Co.
Benchmark Co. believes recent acquisition activity in the orthopedic sector supports its view the shares of Exactech are undervalued. The firm thinks the company's Extremity product line represents significant value for shareholders and reiterates a Buy rating on the name. | |
|
News For EXAC From The Last 14 Days Check below for free stories on EXAC the last two weeks. |
|
|
| May 6, 2013 | | 09:47 EDT |  | EXAC | Exactech announces FDA clearance of Gibralt OCT spine system
 Subscribe for More Information | |
|
|
|
|
|
|
